Pharmacovigilance Outsourcing Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Contract Research Organizations (CROs)
1.2.3 Business Process Outsourcing (BPOs)
1.3 Market by Application
1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Premarketing Clinical Trial
1.3.3 Post-marketing Clinical Practice
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmacovigilance (PV) Outsourcing Market Perspective (2017-2028)
2.2 Pharmacovigilance (PV) Outsourcing Growth Trends by Region
2.2.1 Pharmacovigilance (PV) Outsourcing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmacovigilance (PV) Outsourcing Historic Market Size by Region (2017-2022)
2.2.3 Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2023-2028)
2.3 Pharmacovigilance (PV) Outsourcing Market Dynamics
2.3.1 Pharmacovigilance (PV) Outsourcing Industry Trends
2.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers
2.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges
2.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue
3.1.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue (2017-2022)
3.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2017-2022)
3.2 Global Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue
3.4 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio
3.4.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2021
3.5 Pharmacovigilance (PV) Outsourcing Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service
3.7 Date of Enter into Pharmacovigilance (PV) Outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance (PV) Outsourcing Breakdown Data by Type
4.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2017-2022)
4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2023-2028)
5 Pharmacovigilance (PV) Outsourcing Breakdown Data by Application
5.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2017-2022)
5.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
6.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type
6.2.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
6.2.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
6.2.3 North America Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Application
6.3.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
6.3.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
6.3.3 North America Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
6.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Country
6.4.1 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
6.4.2 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
7.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type
7.2.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
7.2.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
7.2.3 Europe Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application
7.3.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
7.3.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
7.3.3 Europe Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
7.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country
7.4.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
7.4.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
8.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type
8.2.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
8.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application
8.3.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
8.4 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region
8.4.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
9.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type
9.2.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
9.2.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
9.2.3 Latin America Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
9.3 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application
9.3.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
9.3.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
9.3.3 Latin America Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
9.4 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country
9.4.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
9.4.2 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2017-2028)
10.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type
10.2.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Type (2017-2028)
10.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application
10.3.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Share by Application (2017-2028)
10.4 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country
10.4.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Accenture
11.1.1 Accenture Company Details
11.1.2 Accenture Business Overview
11.1.3 Accenture Pharmacovigilance (PV) Outsourcing Introduction
11.1.4 Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.1.5 Accenture Recent Developments
11.2 C3i Solutions
11.2.1 C3i Solutions Company Details
11.2.2 C3i Solutions Business Overview
11.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Introduction
11.2.4 C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.2.5 C3i Solutions Recent Developments
11.3 Clintec
11.3.1 Clintec Company Details
11.3.2 Clintec Business Overview
11.3.3 Clintec Pharmacovigilance (PV) Outsourcing Introduction
11.3.4 Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.3.5 Clintec Recent Developments
11.4 Covance
11.4.1 Covance Company Details
11.4.2 Covance Business Overview
11.4.3 Covance Pharmacovigilance (PV) Outsourcing Introduction
11.4.4 Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.4.5 Covance Recent Developments
11.5 Deloitte Touche Tohmatsu Limited
11.5.1 Deloitte Touche Tohmatsu Limited Company Details
11.5.2 Deloitte Touche Tohmatsu Limited Business Overview
11.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Introduction
11.5.4 Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
11.6 ELC Group
11.6.1 ELC Group Company Details
11.6.2 ELC Group Business Overview
11.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Introduction
11.6.4 ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.6.5 ELC Group Recent Developments
11.7 Ergomed
11.7.1 Ergomed Company Details
11.7.2 Ergomed Business Overview
11.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Introduction
11.7.4 Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.7.5 Ergomed Recent Developments
11.8 iGATE Corporation
11.8.1 iGATE Corporation Company Details
11.8.2 iGATE Corporation Business Overview
11.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.8.4 iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.8.5 iGATE Corporation Recent Developments
11.9 iMED Global Corporation
11.9.1 iMED Global Corporation Company Details
11.9.2 iMED Global Corporation Business Overview
11.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.9.4 iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.9.5 iMED Global Corporation Recent Developments
11.10 IQVIA
11.10.1 IQVIA Company Details
11.10.2 IQVIA Business Overview
11.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Introduction
11.10.4 IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.10.5 IQVIA Recent Developments
11.11 MarksMan Healthcare
11.11.1 MarksMan Healthcare Company Details
11.11.2 MarksMan Healthcare Business Overview
11.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Introduction
11.11.4 MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.11.5 MarksMan Healthcare Recent Developments
11.12 Medpace Holdings
11.12.1 Medpace Holdings Company Details
11.12.2 Medpace Holdings Business Overview
11.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Introduction
11.12.4 Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.12.5 Medpace Holdings Recent Developments
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Pharmacovigilance (PV) Outsourcing Introduction
11.13.4 Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.13.5 Novartis Recent Developments
11.14 Oracle Corporation
11.14.1 Oracle Corporation Company Details
11.14.2 Oracle Corporation Business Overview
11.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.14.4 Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.14.5 Oracle Corporation Recent Developments
11.15 Parexel
11.15.1 Parexel Company Details
11.15.2 Parexel Business Overview
11.15.3 Parexel Pharmacovigilance (PV) Outsourcing Introduction
11.15.4 Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.15.5 Parexel Recent Developments
11.16 PharmInvent
11.16.1 PharmInvent Company Details
11.16.2 PharmInvent Business Overview
11.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Introduction
11.16.4 PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.16.5 PharmInvent Recent Developments
11.17 PrimeVigilance
11.17.1 PrimeVigilance Company Details
11.17.2 PrimeVigilance Business Overview
11.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Introduction
11.17.4 PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.17.5 PrimeVigilance Recent Developments
11.18 Pure Drug Safety
11.18.1 Pure Drug Safety Company Details
11.18.2 Pure Drug Safety Business Overview
11.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Introduction
11.18.4 Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.18.5 Pure Drug Safety Recent Developments
11.19 Sciformix
11.19.1 Sciformix Company Details
11.19.2 Sciformix Business Overview
11.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Introduction
11.19.4 Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.19.5 Sciformix Recent Developments
11.20 SIRO Clinpharm
11.20.1 SIRO Clinpharm Company Details
11.20.2 SIRO Clinpharm Business Overview
11.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Introduction
11.20.4 SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.20.5 SIRO Clinpharm Recent Developments
11.21 Symogen
11.21.1 Symogen Company Details
11.21.2 Symogen Business Overview
11.21.3 Symogen Pharmacovigilance (PV) Outsourcing Introduction
11.21.4 Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
11.21.5 Symogen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Contract Research Organizations (CROs)
Table 3. Key Players of Business Process Outsourcing (BPOs)
Table 4. Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Pharmacovigilance (PV) Outsourcing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2017-2022)
Table 8. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Pharmacovigilance (PV) Outsourcing Market Share by Region (2023-2028)
Table 10. Pharmacovigilance (PV) Outsourcing Market Trends
Table 11. Pharmacovigilance (PV) Outsourcing Market Drivers
Table 12. Pharmacovigilance (PV) Outsourcing Market Challenges
Table 13. Pharmacovigilance (PV) Outsourcing Market Restraints
Table 14. Global Pharmacovigilance (PV) Outsourcing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Players (2017-2022)
Table 16. Global Top Pharmacovigilance (PV) Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2021)
Table 17. Ranking of Global Top Pharmacovigilance (PV) Outsourcing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service
Table 21. Date of Enter into Pharmacovigilance (PV) Outsourcing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2017-2022)
Table 25. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Type (2023-2028)
Table 27. Global Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2017-2022)
Table 29. Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Pharmacovigilance (PV) Outsourcing Revenue Share by Application (2023-2028)
Table 31. North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2023-2028) & (US$ Million)
Table 61. Accenture Company Details
Table 62. Accenture Business Overview
Table 63. Accenture Pharmacovigilance (PV) Outsourcing Product
Table 64. Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 65. Accenture Recent Developments
Table 66. C3i Solutions Company Details
Table 67. C3i Solutions Business Overview
Table 68. C3i Solutions Pharmacovigilance (PV) Outsourcing Product
Table 69. C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 70. C3i Solutions Recent Developments
Table 71. Clintec Company Details
Table 72. Clintec Business Overview
Table 73. Clintec Pharmacovigilance (PV) Outsourcing Product
Table 74. Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 75. Clintec Recent Developments
Table 76. Covance Company Details
Table 77. Covance Business Overview
Table 78. Covance Pharmacovigilance (PV) Outsourcing Product
Table 79. Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 80. Covance Recent Developments
Table 81. Deloitte Touche Tohmatsu Limited Company Details
Table 82. Deloitte Touche Tohmatsu Limited Business Overview
Table 83. Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product
Table 84. Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 85. Deloitte Touche Tohmatsu Limited Recent Developments
Table 86. ELC Group Company Details
Table 87. ELC Group Business Overview
Table 88. ELC Group Pharmacovigilance (PV) Outsourcing Product
Table 89. ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 90. ELC Group Recent Developments
Table 91. Ergomed Company Details
Table 92. Ergomed Business Overview
Table 93. Ergomed Pharmacovigilance (PV) Outsourcing Product
Table 94. Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 95. Ergomed Recent Developments
Table 96. iGATE Corporation Company Details
Table 97. iGATE Corporation Business Overview
Table 98. iGATE Corporation Pharmacovigilance (PV) Outsourcing Product
Table 99. iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 100. iGATE Corporation Recent Developments
Table 101. iMED Global Corporation Company Details
Table 102. iMED Global Corporation Business Overview
Table 103. iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product
Table 104. iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 105. iMED Global Corporation Recent Developments
Table 106. IQVIA Company Details
Table 107. IQVIA Business Overview
Table 108. IQVIA Pharmacovigilance (PV) Outsourcing Product
Table 109. IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 110. IQVIA Recent Developments
Table 111. MarksMan Healthcare Company Details
Table 112. MarksMan Healthcare Business Overview
Table 113. MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product
Table 114. MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 115. MarksMan Healthcare Recent Developments
Table 116. Medpace Holdings Company Details
Table 117. Medpace Holdings Business Overview
Table 118. Medpace Holdings Pharmacovigilance (PV) Outsourcing Product
Table 119. Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 120. Medpace Holdings Recent Developments
Table 121. Novartis Company Details
Table 122. Novartis Business Overview
Table 123. Novartis Pharmacovigilance (PV) Outsourcing Product
Table 124. Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 125. Novartis Recent Developments
Table 126. Oracle Corporation Company Details
Table 127. Oracle Corporation Business Overview
Table 128. Oracle Corporation Pharmacovigilance (PV) Outsourcing Product
Table 129. Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 130. Oracle Corporation Recent Developments
Table 131. Parexel Company Details
Table 132. Parexel Business Overview
Table 133. Parexel Pharmacovigilance (PV) Outsourcing Product
Table 134. Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 135. Parexel Recent Developments
Table 136. PharmInvent Company Details
Table 137. PharmInvent Business Overview
Table 138. PharmInvent Pharmacovigilance (PV) Outsourcing Product
Table 139. PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 140. PharmInvent Recent Developments
Table 141. PrimeVigilance Company Details
Table 142. PrimeVigilance Business Overview
Table 143. PrimeVigilance Pharmacovigilance (PV) Outsourcing Product
Table 144. PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 145. PrimeVigilance Recent Developments
Table 146. Pure Drug Safety Company Details
Table 147. Pure Drug Safety Business Overview
Table 148. Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product
Table 149. Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 150. Pure Drug Safety Recent Developments
Table 151. Sciformix Company Details
Table 152. Sciformix Business Overview
Table 153. Sciformix Pharmacovigilance (PV) Outsourcing Product
Table 154. Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 155. Sciformix Recent Developments
Table 156. SIRO Clinpharm Company Details
Table 157. SIRO Clinpharm Business Overview
Table 158. SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product
Table 159. SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 160. SIRO Clinpharm Recent Developments
Table 161. Symogen Company Details
Table 162. Symogen Business Overview
Table 163. Symogen Pharmacovigilance (PV) Outsourcing Product
Table 164. Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2017-2022) & (US$ Million)
Table 165. Symogen Recent Developments
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacovigilance (PV) Outsourcing Market Share by Type: 2021 VS 2028
Figure 2. Contract Research Organizations (CROs) Features
Figure 3. Business Process Outsourcing (BPOs) Features
Figure 4. Global Pharmacovigilance (PV) Outsourcing Market Share by Application: 2021 VS 2028
Figure 5. Premarketing Clinical Trial Case Studies
Figure 6. Post-marketing Clinical Practice Case Studies
Figure 7. Other Case Studies
Figure 8. Pharmacovigilance (PV) Outsourcing Report Years Considered
Figure 9. Global Pharmacovigilance (PV) Outsourcing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Pharmacovigilance (PV) Outsourcing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Pharmacovigilance (PV) Outsourcing Market Share by Region: 2021 VS 2028
Figure 12. Global Pharmacovigilance (PV) Outsourcing Market Share by Players in 2021
Figure 13. Global Top Pharmacovigilance (PV) Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (PV) Outsourcing as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Pharmacovigilance (PV) Outsourcing Revenue in 2021
Figure 15. North America Pharmacovigilance (PV) Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Pharmacovigilance (PV) Outsourcing Market Size Market Share by Type (2017-2028)
Figure 17. North America Pharmacovigilance (PV) Outsourcing Market Size Market Share by Application (2017-2028)
Figure 18. North America Pharmacovigilance (PV) Outsourcing Market Size Share by Country (2017-2028)
Figure 19. United States Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Pharmacovigilance (PV) Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Pharmacovigilance (PV) Outsourcing Market Size Market Share by Type (2017-2028)
Figure 23. Europe Pharmacovigilance (PV) Outsourcing Market Size Market Share by Application (2017-2028)
Figure 24. Europe Pharmacovigilance (PV) Outsourcing Market Size Share by Country (2017-2028)
Figure 25. Germany Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Pharmacovigilance (PV) Outsourcing Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Pharmacovigilance (PV) Outsourcing Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Pharmacovigilance (PV) Outsourcing Market Size Share by Region (2017-2028)
Figure 35. China Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Pharmacovigilance (PV) Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Pharmacovigilance (PV) Outsourcing Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Pharmacovigilance (PV) Outsourcing Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Pharmacovigilance (PV) Outsourcing Market Size Share by Country (2017-2028)
Figure 45. Mexico Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Pharmacovigilance (PV) Outsourcing Market Size Share by Country (2017-2028)
Figure 51. Turkey Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Pharmacovigilance (PV) Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Accenture Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 55. C3i Solutions Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 56. Clintec Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 57. Covance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 58. Deloitte Touche Tohmatsu Limited Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 59. ELC Group Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 60. Ergomed Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 61. iGATE Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 62. iMED Global Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 63. IQVIA Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 64. MarksMan Healthcare Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 65. Medpace Holdings Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 66. Novartis Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 67. Oracle Corporation Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 68. Parexel Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 69. PharmInvent Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 70. PrimeVigilance Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 71. Pure Drug Safety Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 72. Sciformix Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 73. SIRO Clinpharm Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 74. Symogen Revenue Growth Rate in Pharmacovigilance (PV) Outsourcing Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed